secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001161697-26-000055
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Linda Tharby to retire June 2026; Adam Kalbermatten named successor
-----------------------------------------------------------------------

- Tharby retires as CEO effective June 30, 2026; will serve as advisory employee through Dec 31, 2026.
- Kalbermatten appointed President March 15, 2026, and becomes CEO July 1, 2026.
- Kalbermatten's base salary: $450K through June, then $525K; 2026 bonus target 80%; LTI target $1.25M.
- One-time PSU award of $1.25M to Kalbermatten effective July 1, 2026 with performance goals (75% revenue growth, 25% market cap).
- Tharby's equity: some PSUs/RSUs continue vesting through Dec 31, 2026; all remaining unvested awards forfeited thereafter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000055/0001161697-26-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000055/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-26-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer